← Back to 119-S3267

Bill text

ASAP Act

119-S3267Introduced in Senate11/20/20252,261 characters

This is the text of the Introduced in Senate version, as published by the U.S. Government Publishing Office. Heard added line breaks and the quotation marks the printed bill shows; the words are unchanged. Bills change as they move, so check the official document for the current version. Heard is not affiliated with the U.S. Government Publishing Office.

II 119th CONGRESS 1st Session S. 3267 IN THE SENATE OF THE UNITED STATES November 20, 2025 Ms. Collins (for herself, Ms. Cortez Masto , Mrs. Capito , and Mr. Warner ) introduced the following bill; which was read twice and referred to the Committee on Finance A BILL To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests. 1. Short title This Act may be cited as the “Alzheimer's Screening and Prevention Act” or the “ASAP Act”. 2. Medicare coverage of Alzheimer’s disease and related dementias early detection screening tests (a) Coverage Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended— (1) in subsection (s)(2)— (A) in subparagraph (JJ), by striking the semicolon at the end and inserting “; and”; and (B) by adding at the end the following new subparagraph: (KK) Alzheimer’s disease and related dementias early detection screening tests (as defined in subsection (nnn)); and (2) by adding at the end the following new subsection: (nnn) Alzheimer’s disease and related dementias early detection screening tests The term Alzheimer’s disease and related dementias early detection screening test means a test furnished to an individual for the detection of the pre-symptomatic and early stage of Alzheimer’s disease or related dementias on or after January 1, 2028, that— (1) is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act; and (2) is— (A) a genomic sequencing blood or blood product test; or (B) such other equivalent test, including a single-analyte test, blood test analysis of cell-free nucleic acids, multiplex panel test, whole genome sequencing, protein expression, whole exome, whole transcriptome, and medical imaging (which are based on blood, blood products, tissue, urine or other biospecimen), as the Secretary determines appropriate in providing results comparable to those obtained with a test described in subparagraph (A). . (b) Payment Section 1833(h)(1)(A) of the Social Security Act (42 U.S.C. 1395l(h)(1)(A)) is amended by inserting “Alzheimer’s disease and related dementias early detection screening tests under section 1861(nnn) and” after “including”.
Verify this text
SHA-256 of the file
d60b81cb5d11d92ac17c707cdb72b918a8fad8913d4cc6d79d455c1ba0c0ce89
Fetched
10/21/2026, 1:31:59 AM